Updated
Updated · Reuters · Nov 12
AMD to Invest in PsiQuantum as Pair Build Utility-Scale Quantum Computing Infrastructure
Updated
Updated · Reuters · Nov 12

AMD to Invest in PsiQuantum as Pair Build Utility-Scale Quantum Computing Infrastructure

3 articles · Updated · Reuters · Nov 12

Summary

  • AMD plans an equity investment in PsiQuantum as the two expand a partnership to build the infrastructure needed for utility-scale quantum computers; financial terms were not disclosed.
  • The companies will co-design systems that combine quantum computing with high-performance computing and AI, with AMD supplying CPUs, GPUs, adaptive computing technology and software, and PsiQuantum contributing its silicon photonics platform.
  • PsiQuantum said its drug-research technology already runs on AMD hardware and has produced more accurate results than existing methods, including early gains in simulating covalent inhibitors used in oncology drug discovery.
  • Quantum computing has drawn fresh capital as governments and companies chase breakthroughs in drug discovery, financial modeling and cryptography; in May, the U.S. Commerce Department included PsiQuantum in a $2 billion CHIPS Act push, with a $100 million deal.

Insights

Will AMD's undisclosed investment in light-based quantum chips finally unlock fault-tolerant computing through hybrid integration?
How will the fusion of AMD GPUs and silicon photonics revolutionize oncology drug discovery before the decade ends?